MAUREEN THYNE: Open Payments
NPI 1316194020 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,439 in 33 payments from 5 companies in 2025. Trend: 2023 $27,400 · 2024 $14,784 · 2025 $16,439
Speaker / faculty: $9,338Travel & lodging: $6,148Food & beverage: $848Consulting: $105
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 29 | $16,255 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Celgene Corporation | 1 | $16 |
Products named: Jakafi, OJJAARA, Vanflyta, REBLOZYL.
Industry payments across NY — which companies pay providers there.
